OtoNexus Medical Technologies Selected for Elite FDA STeP Program
FDA STeP Program awarded to OtoNexus Medical Technologies for ultrasound platform technology that evaluates middle ear infections. SEATTLE, Dec. 6, 2023 /PRNewswire/ — OtoNexus Medical Technologies, the developer of the Novoscope ultrasound otoscope for immediate and automatic differentiation of bacterial... Read More →
Bone Health Technologies Earns 4th Patent for Osteoboost Device
Recognizes the invention as a wearable apparatus focused on the treatment or prevention of osteopenia or osteoporosis. Bone Health Technologies (BHT), an innovator in health technologies to improve bone health, has been granted its fourth patent to further its commercialization... Read More →
TIMING to demonstrate reduced AICD and improved motility of hydroporated cells featuring CellChorus and Indee Labs
HOUSTON, Texas — December 5, 2023 — CellChorus Inc., the leader in applying artificial intelligence to visually evaluate how cells perform and interact over time, announced the publication by Indee Labs of a summary of how the CellChorus® TIMING™ platform... Read More →
Nitinotes Surgical in Full Swing: Impressive Board Appointment, Over 90 Patients Treated, 400+ Sutures Performed, and a $10.1M Series B Funding Round Closure
Innovating a new era in endoscopic obesity treatment with Nitinotes’ EndoZip(TM) System, a revolutionary, fully automated suturing device. Nitinotes, developers of EndoZip™, a revolutionary, fully automated suturing device, announced the appointment of Mr. John Barr as the new Chairman of... Read More →
Bright Uro Announces $23M Series A Funding Round Led by Laborie – Expands Senior Leadership Team to Accelerate Next Phase of Commercialization
Company Names Chief Product Development Officer and Chief Commercial Officer as Glean continues to progress to regulatory clearance IRVINE, Calif.–(BUSINESS WIRE)–Bright Uro, a medical device company with a mission to transform care for lower urinary tract symptoms (LUTS) through innovations... Read More →
Inflammatix Receives Breakthrough Device Designation from FDA for TriVerity™ Acute Infection and Sepsis Test System
SUNNYVALE, Calif., Nov. 28, 2023 /PRNewswire/ — Inflammatix, Inc., a pioneering molecular diagnostics company, announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the company’s lead product, the TriVerity™ Acute Infection and Sepsis... Read More →
FormaPath (formerly Parker Isaac Instruments) Announces Advancement in Cancer Pathology With the Launch of AdiPress
Cutting-edge medical technology company launches the first-ever, automated tool for lymph node dissection to support cancer staging for patients with solid tumors ITHACA, N.Y., Nov. 28, 2023 /PRNewswire/ — Today, FormaPath announced the commercial launch of AdiPress, the first and... Read More →
Savage Medical Exits Stealth With Over $3 Million to Enable Minimally Invasive Colorectal Tumor Removal
SAN FRANCISCO, Nov. 28, 2023 /PRNewswire/ — Savage Medical, Inc. (“SavageMed”, “Company”, “We”, or “Us”), a San Francisco Bay Area-based, clinical-stage medical technology company enabling minimally invasive colorectal tumor removal, today announced a launch out of stealth with over $3... Read More →
Pristine Surgical fully launches single-use arthroscope in the U.S.
Pristine Surgical announced today that it accelerated the launch of its first-of-its-kind Summit 4K single-use surgical arthroscope. Summit combines a 4K single-use surgical arthroscope with the company’s cloud-based software Pristine Connect. The device provides a high-definition image every time. Read... Read More →
Kheiron’s AI Tool Mia Increases Breast Cancer Detection Rate by 13%, Nature Study Reveals
UK-based cancertech company Kheiron has made a significant leap in the fight against breast cancer with their AI tool, Mia, as evidenced by a recent study published in Nature Medicine. According to the new paper Mia has demonstrated the ability... Read More →